A Canadian woman who has long suffered from interstitial cystitis found remarkable relief from the condition, but now she is voluntarily returning to her discomfort out of fear of Elmiron vision loss. Carrie Gagno lives in Toronto, Canada. She has been taking Elmiron – also known by its generic name of pentosan polysulfate sodium – for 15 years, ever since her physician prescribed it for the painful bladder syndrome. But now that her physician has learned of its risk and made her aware, she has voluntarily given up the medication.
In August of 2018, a California jury awarded California school groundskeeper Dewayne “Lee” Johnson $289 million in damages in his personal injury lawsuit accusing Monsanto’s Roundup weed killer of causing his cancer. Though the trial judge later lowered that award – which included $250 million in punitive damages – to $78.5 million, Monsanto and its new owner Bayer appealed the verdict, asking that the decision either be reversed or reversed and remanded for a new trial. The company argued that key evidence had been excluded and that at the very least the award for “future noneconomic damages” should be reduced from $33 million to $1.5 million because Johnson is likely to die soon and would not suffer long-term pain and suffering.
As lawsuits continue to be filed against the companies behind Juul e-cigarettes and more and more people become addicted or are sickened by the product, researchers from the Harvard T.H. Chan School of Public Health have just published an abstract detailing their most recent discovery: the product’s tobacco- and menthol-flavored liquids showed signs of being contaminated with microbial toxins.
Though there is a tremendous national interest in the litigation surrounding Zantac cancer, forward movement on the case has been significantly stymied by the COVID-19 crisis. In a March 20th notice that went out from United States District Court, S.D. Florida to hundreds of plaintiffs, their legal counsel, and defense attorneys alike, the court reviewed and updated the status of the case and how its schedule had been impacted. The case involves Zantac and its generic version ranitidine, which has been cited in product liability litigation accusing the manufacturers and designers of selling a product that it knew could cause cancer, without providing appropriate protections or warnings.
Whether you’re a weekend gardener or a fulltime professional landscaper or gardener, you’ve probably heard about the lawsuits being filed by victims of Roundup cancer. Roundup is the most popular weed killer in the market, and its main ingredient is glyphosate. The product’s manufacturer, Monsanto, has been named in over 13,000 lawsuits filed by people who have been diagnosed with cancer that they blame on the product. Though the company claims the product is safe, the World Health Organization has issued warnings calling it “probably carcinogenic to humans.”
Despite receiving many reports from consumers about Elmiron vision loss, Janssen Pharmaceuticals, Inc. and Johnson & Johnson continued marketing the prescription drug to people suffering from interstitial cystitis and bladder pain, providing them with no warnings or notice about the dangers posed by the medication. Even after multiple scientific papers have been published in medical literature and making changes to labeling in other countries, warning users of the potential for injury, the companies made no such changes in the United States.
Over the last few years, Juul e-cigarettes have faced multiple lawsuits accusing the company of furthering the scourge of vaping among teens and adolescents. The use of the products has been accused of causing significant adverse health effects by local school districts, individual parents, and lawmakers alike. Yet despite the negative publicity that has been highlighted in these pending lawsuits, Altria, the company now responsible for marketing the popular electronic vapor delivery products has continued to market its harmful product and has even shown a significant increase in the amount of social media advertising making its way to the market.
Being diagnosed with cancer has long been one of the top fears for people all around the world. In response people have made significant lifestyle changes: they’ve taken up exercise, lost weight, given up smoking, and adopted healthier diets. Now that the FDA has indicated a cancer risk from long-term use of Zantac or any of its generic versions, many are now giving up the popular heartburn drug, even if they had been taking it based upon their physician’s recommendations or a prescription.
As thousands of members of the military are pursuing compensation for hearing damage they blame on 3M combat earplugs, a judge hearing the case ordered the company’s internal documents released. They reveal the fact that the company was well aware of the defect in the product. They also make clear the fact that the company failed to adequately alert the military of the problem, thus leaving soldiers vulnerable to significant harm.
Late March of this year saw the end of Roundup cancer victim Edward Hardeman’s several-year pursuit of justice. Hardeman had used the product over nearly three decades to control weeds and poison oak on his property when he was diagnosed with non-Hodgkin’s lymphoma in 2015. When he learned that the World Health Organization’s International Agency for Research on Cancer had declared the product’s active ingredient, glyphosate, a probable carcinogen, he filed a lawsuit against its maker Monsanto and is only the second among thousands of plaintiffs to have his case heard by a jury. He was awarded more than $80 million in damages.
Danziger & De Llano, LLP. Office Locations: (Principal Office) Houston, Texas . Contact Danziger & De Llano for more information. Prior results do not guarentee or predict a similar outcome with respect to any future matter.